JPH10508826A - シグマ２選択性リガンドである新規アルキルアミノ誘導体 - Google Patents

シグマ２選択性リガンドである新規アルキルアミノ誘導体

Info

Publication number
JPH10508826A
JPH10508826A JP8507194A JP50719496A JPH10508826A JP H10508826 A JPH10508826 A JP H10508826A JP 8507194 A JP8507194 A JP 8507194A JP 50719496 A JP50719496 A JP 50719496A JP H10508826 A JPH10508826 A JP H10508826A
Authority
JP
Japan
Prior art keywords
adamantyl
alkyl
ylmethyl
ethanol
piperidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8507194A
Other languages
English (en)
Japanese (ja)
Inventor
ジャン−フィリップ ロシェ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Publication of JPH10508826A publication Critical patent/JPH10508826A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP8507194A 1994-08-16 1995-08-10 シグマ２選択性リガンドである新規アルキルアミノ誘導体 Pending JPH10508826A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9416571A GB9416571D0 (en) 1994-08-16 1994-08-16 Novel alkylamino derivatives as sigma 2 selective ligands
GB9416571.9 1994-08-16
PCT/JP1995/001600 WO1996005185A1 (fr) 1994-08-16 1995-08-10 Nouveaux derives alkylamino utilises comme ligands selectifs sigma 2

Publications (1)

Publication Number Publication Date
JPH10508826A true JPH10508826A (ja) 1998-09-02

Family

ID=10759952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8507194A Pending JPH10508826A (ja) 1994-08-16 1995-08-10 シグマ２選択性リガンドである新規アルキルアミノ誘導体

Country Status (7)

Country Link
EP (1) EP0777660A1 (fr)
JP (1) JPH10508826A (fr)
KR (1) KR970705550A (fr)
CN (1) CN1164856A (fr)
CA (1) CA2197172A1 (fr)
GB (1) GB9416571D0 (fr)
WO (1) WO1996005185A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014521678A (ja) * 2011-08-02 2014-08-28 ヘルムホルツ ツェントラム ミュンヘン ドイチェス フォーシュングスツェントラム フュール ゲズントハイト ウント ウンヴェルト ゲーエムベーハー フェノチアジン誘導体によるｍａｌｔ１プロテアーゼの選択的阻害
JP2024521231A (ja) * 2021-05-21 2024-05-28 フォンダッツィオーネ テレソン イーティーエス ＰｒＰＣのモジュレーター及びその使用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0881220A4 (fr) * 1996-02-15 1999-04-21 Mitsubishi Chem Corp Derives du diarylsultame
WO1999023083A1 (fr) * 1997-11-05 1999-05-14 Mitsubishi Chemical Corporation Nouveaux derives alkylamino
WO2002002488A2 (fr) * 2000-06-30 2002-01-10 The Regents Of The University Of California Procedes et composes pour moduler la fixation de coactivateurs a des recepteurs nucleaires
AU2002357619A1 (en) * 2001-12-21 2003-07-09 Taisho Pharmaceutical Co., Ltd. Piperazine derivative
US20050032827A1 (en) * 2003-06-12 2005-02-10 Donna Oksenberg Sigma ligands for neuronal regeneration and functional recovery
US7417040B2 (en) 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
WO2021236879A1 (fr) 2020-05-20 2021-11-25 The Board Of Trustees Of The University Of Illinois Méthode de traitement de maladies lysosomales à l'aide de peptides d'histatine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90858A (en) * 1988-07-07 1994-08-26 Rhone Poulenc Sante Derivatives of (AZA) naphthalensultam, their preparation and compositions containing them
KR927002347A (ko) * 1989-10-27 1992-09-03 레이몬드 지. 아너 (n-프탈이미도알킬) 피페리딘
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
JPH06509069A (ja) * 1991-06-27 1994-10-13 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンドおよびその用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014521678A (ja) * 2011-08-02 2014-08-28 ヘルムホルツ ツェントラム ミュンヘン ドイチェス フォーシュングスツェントラム フュール ゲズントハイト ウント ウンヴェルト ゲーエムベーハー フェノチアジン誘導体によるｍａｌｔ１プロテアーゼの選択的阻害
JP2024521231A (ja) * 2021-05-21 2024-05-28 フォンダッツィオーネ テレソン イーティーエス ＰｒＰＣのモジュレーター及びその使用

Also Published As

Publication number Publication date
EP0777660A1 (fr) 1997-06-11
CA2197172A1 (fr) 1996-02-22
KR970705550A (ko) 1997-10-09
CN1164856A (zh) 1997-11-12
WO1996005185A1 (fr) 1996-02-22
GB9416571D0 (en) 1994-10-12

Similar Documents

Publication Publication Date Title
Moltzen et al. Bioisosteres of arecoline: 1, 2, 3, 6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1, 2, 3-triazoles. Synthesis and muscarinic activity
JP3647051B2 (ja) イミダゾール化合物、その製造方法及びその使用方法
FI86421B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 9-amino-1,2,3,4-tetrahydroakridin-1-oler.
AU624280B2 (en) Heterocyclic derivatives, their preparation and medicinal products containing them
HU215848B (hu) Eljárás kvaterner biciklusos aminok, és a vegyületeket tartalmazó gyógyszerkészítmények előállítására
PT862567E (pt) 5-azabiciclo(3.1.0)hexilalquil-2-piperidonas e -glutarimidas como antagonistas do receptor de neurocinina
TW314518B (fr)
MXPA02006499A (es) Derivados de fenilpiperazinilo.
HU199141B (en) Process for producing 1-square brackets open pyrimidin-2-yl-(aminoalkyl) square brackets closed-piperidine derivatives and pharmaceutical compositions comprising same
DE69829317T2 (de) Tetrahydrobenzindol-derivate
EP0881220A1 (fr) Derives du diarylsultame
MX2007007894A (es) Antagonistas del receptor 5-ht7.
WO1996005185A1 (fr) Nouveaux derives alkylamino utilises comme ligands selectifs sigma 2
ES2257168B1 (es) Ligandos del receptor 5-ht7.
KR100335548B1 (ko) 중추신경계활성을갖는헤테로사이클아민
PL177947B1 (pl) Nowe związki tetrahydroizochinolinowe, kompozycja farmaceutyczna i sposób wytwarzania nowych związków tetrahydroizochinolinowych
TWI244485B (en) Tricyclic Delta3-piperidines as pharmaceuticals
EP1630158A1 (fr) Antagonistes des recepteurs 5-HT7
NZ231943A (en) N-(4-pyridinyl)-9h-carbazol-9-amine derivatives, preparatory processes and pharmaceutical compositions
CN101010301A (zh) 5－ht7受体拮抗剂
KR100235506B1 (ko) 5-아미노-5,6,7,8-테트라하이드로퀴놀린 및 관련화합물,이의 제조방법 및 약제로서의 이의 용도
EP1676840A1 (fr) Antagonists du recepteur 5-HT7
JPH0735373B2 (ja) カルボン酸アミド化合物
JPS5970675A (ja) ベンゾオキサジン誘導体
JPWO1997030038A1 (ja) ジアリールスルタン誘導体